Supreme Pharmaceuticals Inc

FIRE-X

CVE:FIRE

2.26
0.12 (5.61%)
The Supreme Cannabis Co Inc is engaged in production and sale of medical cannabis. The company is a cultivator and distributor of sun-grown cannabis through its wholly-owned subsidiary 7ACRES.
More at Wikipedia

Analysis and Opinions about FIRE-X

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
August 16, 2019
Go all in into this? Don't go all in into any cannabis stock, a sector that hasn't shown earnings yet. He has a convertible debenture of Supreme, who have executed well. But this space is now under tremendous pressure, ever since legalization.
Show full opinionHide full opinion
Go all in into this? Don't go all in into any cannabis stock, a sector that hasn't shown earnings yet. He has a convertible debenture of Supreme, who have executed well. But this space is now under tremendous pressure, ever since legalization.
BUY
BUY
July 22, 2019
One of the better cannabis growers, producing high-quality flower which pays wider margins. Well-run. Stick with this, though this space has pulled back lately after scaling nosebleed high valuations just a few months ago.
Show full opinionHide full opinion
One of the better cannabis growers, producing high-quality flower which pays wider margins. Well-run. Stick with this, though this space has pulled back lately after scaling nosebleed high valuations just a few months ago.
WATCH
WATCH
October 17, 2018

He has looked closely at this and now sees them stepping out to provide high quality bud to other producers. They just signed a major contract to supply Tilray (TLRY-N), which he feels adds substantial credibility to their business model. The risk lies in them not having a distinct brand.

Show full opinionHide full opinion

He has looked closely at this and now sees them stepping out to provide high quality bud to other producers. They just signed a major contract to supply Tilray (TLRY-N), which he feels adds substantial credibility to their business model. The risk lies in them not having a distinct brand.

DON'T BUY
DON'T BUY
August 28, 2018

Everything moved up on Monday, it felt like a compulsory buy. He used to own it but owns only debentures and warrants now. It’s a plain vanilla cannabis company--growers. They don’t plan to retail, they plan to sell to retailers. They seem to know what they’re doing, but in terms of new investments, there are others that he likes better.

Show full opinionHide full opinion

Everything moved up on Monday, it felt like a compulsory buy. He used to own it but owns only debentures and warrants now. It’s a plain vanilla cannabis company--growers. They don’t plan to retail, they plan to sell to retailers. They seem to know what they’re doing, but in terms of new investments, there are others that he likes better.

COMMENT
COMMENT
March 26, 2018

He owns a convertible debenture and some warrants, but is short some of the stock as a hedge against it. He does not have a particular view in the near term. He sees them as capable operators. He would put them in the upper quartile area of the sector, but believes the cultivators are generally over-valued.

Show full opinionHide full opinion

He owns a convertible debenture and some warrants, but is short some of the stock as a hedge against it. He does not have a particular view in the near term. He sees them as capable operators. He would put them in the upper quartile area of the sector, but believes the cultivators are generally over-valued.

BUY
BUY
August 31, 2017

It is going to have a premium recreational weed product. It really wants to grow good ‘stuff’. When the market comes out there are going to be premium products. They are expanding in a disciplined way and increasing the grow rooms. They are going to have 340,000 sq. ft. by 2019.

Show full opinionHide full opinion

It is going to have a premium recreational weed product. It really wants to grow good ‘stuff’. When the market comes out there are going to be premium products. They are expanding in a disciplined way and increasing the grow rooms. They are going to have 340,000 sq. ft. by 2019.

BUY
BUY
July 6, 2017

Just got its sales license. They have a dried bud business model. Management are smart and are holding back on spending their capital. It is interesting and he likes that they are not making wild expansion plans.

Show full opinionHide full opinion

Just got its sales license. They have a dried bud business model. Management are smart and are holding back on spending their capital. It is interesting and he likes that they are not making wild expansion plans.

BUY
BUY
June 23, 2017

Cannabis. They’ve had their cultivation license for a long time. There should be no problem. Seem to have a well-run operation. Management is fine. Once they get the sales license, there is some good upside in the stock. This is a reasonable time to be picking away at stocks like this.

Show full opinionHide full opinion

Cannabis. They’ve had their cultivation license for a long time. There should be no problem. Seem to have a well-run operation. Management is fine. Once they get the sales license, there is some good upside in the stock. This is a reasonable time to be picking away at stocks like this.

COMMENT
COMMENT
April 26, 2017

A lot of people have been concerned about the sales license with this company. They were very close to getting their sales license from Health Canada, and then there were pesticide issues with some other companies. Health Canada asked the company to look at some of the fertilizers they were using. Now they have to get those onto an approved list before getting their sales license. It’s just a longer review process than what was expected.

Show full opinionHide full opinion

A lot of people have been concerned about the sales license with this company. They were very close to getting their sales license from Health Canada, and then there were pesticide issues with some other companies. Health Canada asked the company to look at some of the fertilizers they were using. Now they have to get those onto an approved list before getting their sales license. It’s just a longer review process than what was expected.

Showing 1 to 9 of 9 entries
  • «
  • 1
  • »

Supreme Pharmaceuticals Inc(FIRE-X) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Supreme Pharmaceuticals Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Supreme Pharmaceuticals Inc(FIRE-X) Frequently Asked Questions

What is Supreme Pharmaceuticals Inc stock symbol?

Supreme Pharmaceuticals Inc is a Canadian stock, trading under the symbol FIRE-X on the TSX Venture Exchange (FIRE-CV). It is usually referred to as TSXV:FIRE or FIRE-X

Is Supreme Pharmaceuticals Inc a buy or a sell?

In the last year, there was no coverage of Supreme Pharmaceuticals Inc published on Stockchase.

Is Supreme Pharmaceuticals Inc a good investment or a top pick?

Supreme Pharmaceuticals Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Supreme Pharmaceuticals Inc.

Why is Supreme Pharmaceuticals Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Supreme Pharmaceuticals Inc worth watching?

0 stock analysts on Stockchase covered Supreme Pharmaceuticals Inc In the last year. It is a trending stock that is worth watching.

What is Supreme Pharmaceuticals Inc stock price?

On 2019-02-02, Supreme Pharmaceuticals Inc (FIRE-X) stock closed at a price of $2.26.